1. Home
  2. CRI vs DAWN Comparison

CRI vs DAWN Comparison

Compare CRI & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$33.21

Market Cap

1.3B

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$10.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
DAWN
Founded
1865
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
CRI
DAWN
Price
$33.21
$10.54
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$34.00
$27.11
AVG Volume (30 Days)
1.0M
1.8M
Earning Date
06-01-2026
05-25-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$2,844,102,000.00
$158,182,000.00
Revenue This Year
$2.49
$47.48
Revenue Next Year
$0.21
$31.10
P/E Ratio
$56.24
N/A
Revenue Growth
N/A
20.60
52 Week Low
$23.38
$5.64
52 Week High
$44.44
$13.20

Technical Indicators

Market Signals
Indicator
CRI
DAWN
Relative Strength Index (RSI) 35.74 44.23
Support Level $28.71 $10.07
Resistance Level $33.53 $10.68
Average True Range (ATR) 1.92 0.66
MACD -0.44 -0.17
Stochastic Oscillator 5.63 11.26

Price Performance

Historical Comparison
CRI
DAWN

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: